Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus
Author:
Affiliation:
1. Janssen Research & Development, LLC; Raritan NJ USA
2. Janssen Research & Development, LLC; San Diego CA USA
3. Profil; Neuss Germany
4. Virginia Commonwealth University Medical Center; Richmond VA USA
Funder
Janssen Global Services, LLC
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12322/fullpdf
Reference34 articles.
1. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise;Stenlöf;Diabetes Obes Metab,2013
2. Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week, randomized trial;Schernthaner;Diabetes Care,2013
3. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease;Yale;Diabetes Obes Metab,2013
4. Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trial;Bode;Hosp Pract,2013
5. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial;Cefalu;Lancet,2013
Cited by 208 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10
2. SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23);Expert Opinion on Therapeutic Patents;2024-08-02
3. Fluid Restriction for Patients with Heart Failure: Current Evidence and Future Perspectives;Journal of Personalized Medicine;2024-07-11
4. Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium–Glucose Cotransporter 2 Inhibitors vs. Non‐Users;Clinical Pharmacology & Therapeutics;2024-05-13
5. Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;BMC Endocrine Disorders;2024-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3